Clinical Scorecard: Mass Spec Roundup: From Alzheimer’s to Antarctic Dust
At a Glance
Category
Detail
Condition
Alzheimer’s disease neuroinflammation
Key Mechanisms
S-nitrosylation of STING at cysteine 148 drives type I interferon signaling, microglial activation, and synaptic damage
Target Population
Patients with Alzheimer’s disease
Care Setting
Research and potential therapeutic development settings
Key Highlights
S-nitrosylation of STING at cysteine 148 identified as a driver of chronic neuroinflammation in Alzheimer’s disease.
Blocking S-nitrosylation of STING in a mouse model reduces neuroinflammatory signaling and protects synapses.
PFAS exposure through nursing in bottlenose dolphins suggests early-life contaminant transfer with potential human health implications.
Guideline-Based Recommendations
Diagnosis
Detection of elevated S-nitrosylated STING in human Alzheimer’s brain samples and disease-relevant cell models may aid research diagnosis.
Management
Development of small molecules targeting cysteine 148 on STING to block S-nitrosylation and reduce damaging neuroinflammation is a promising therapeutic approach.
Monitoring & Follow-up
Monitor neuroinflammatory markers and synaptic integrity in preclinical models when testing STING-targeted interventions.
Risks
Potential risk of disrupting normal immune function when targeting STING; selective interference strategies are needed.
Patient & Prescribing Data
Alzheimer’s disease models and human brain tissue samples
Genetic modification preventing STING S-nitrosylation reduces inflammation and synaptic degeneration; small molecule inhibitors are under development.
Clinical Best Practices
Utilize mass spectrometry and redox chemical biology to identify post-translational modifications driving neuroinflammation.
Consider targeting specific molecular switches such as STING S-nitrosylation to modulate innate immune signaling in neurodegenerative diseases.
Incorporate multi-technique analytical approaches for comprehensive detection of environmental contaminants like PFAS in biological samples.
